Cargando…

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany

BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are associated with progression to advanced liver diseases that include compensated cirrhosis, decompensated cirrhosis, liver transplantation, and hepatocellular carcinoma (HCC). This study cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canbay, Ali, Kachru, Nandita, Haas, Jennifer Scarlet, Meise, Dominic, Ozbay, A. Burak, Sowa, Jan-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106103/ https://www.ncbi.nlm.nih.gov/pubmed/33987313 http://dx.doi.org/10.21037/atm-20-7179

Ejemplares similares

Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases
por: Wong, Robert J., et al.
Publicado: (2021)

Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
por: Romero-Gomez, Manuel, et al.
Publicado: (2020)

Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score
por: Gordon, Stuart C., et al.
Publicado: (2020)

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database
por: Terai, Shuji, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
por: Kocaata, Zeki, et al.
Publicado: (2022)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Surgery in Nonalcoholic Cirrhosis: Clinical Outcomes, Healthcare Utilization, and Cost Analysis
por: Tait, Christopher, et al.
Publicado: (2023)

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
por: Canbay, Ali, et al.
Publicado: (2019)

The utility of ezetimibe therapy in nonalcoholic fatty liver disease
por: Jun, Baek Gyu, et al.
Publicado: (2019)

Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014–2019: a retrospective cohort study
por: Hu, Tianyan, et al.
Publicado: (2023)

A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease
por: Manka, Paul P., et al.
Publicado: (2021)

The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization
por: Schwarting, Andreas, et al.
Publicado: (2021)

Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis
por: Sayiner, Mehmet, et al.
Publicado: (2017)

Long-term exposure to air pollution and prevalent nonalcoholic fatty liver disease
por: Matthiessen, Clara, et al.
Publicado: (2023)

Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis
por: Fiehn, Christoph, et al.
Publicado: (2023)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Healthcare resource utilization and costs associated with anogenital warts in Morocco
por: Berrada, Myriam, et al.
Publicado: (2021)

Cost Saving or Cost Effective? Unanswered Questions in the Screening of Patients With Nonalcoholic Fatty Liver Disease
por: Jiang, Z. Gordon, et al.
Publicado: (2019)

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Mowry, Christopher J., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis
por: Quignot, Nadia, et al.
Publicado: (2023)

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
por: Rampakakis, Emmanouil, et al.
Publicado: (2019)

Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
por: Greven, Peter, et al.
Publicado: (2016)

Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study
por: Sung, Ki-Chul, et al.
Publicado: (2019)

Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study
por: Schmidt, Konrad F. R., et al.
Publicado: (2022)

Economic burden of secondary hyperparathyroidism in Germany: a matched comparison
por: Reichel, Helmut, et al.
Publicado: (2022)

Chronic kidney disease in nonalcoholic fatty liver disease at primary healthcare centers in Korea
por: Nah, Eun-Hee, et al.
Publicado: (2022)

Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
por: Tafalla, Monica, et al.
Publicado: (2010)

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
por: Voorham, Jaco, et al.
Publicado: (2018)

Temporal trends in healthcare resource utilization and costs following acute myocardial infarction
por: Shiyovich, Arthur, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
por: Watanabe, Tomone, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
por: Blanchette, Christopher M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mq08dh5aa90t299a6k22lnaid6